Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Cash Flow from Operations

Arcus Biosciences Inc Cash Flow from Operations Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Cash Flow from Operations from 2017 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Arcus Biosciences Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-7m a -86.39% increase of 6m year over year
  • Arcus Biosciences Inc Cash Flow from Operations for the last 12 months ending December 12, 2018 was $-43m a 33.23% decrease of -14m year over year
  • Arcus Biosciences Inc Annual Cash Flow from Operations for 2018 was $-43m a 41.72% decrease of -18m from 2017
  • Arcus Biosciences Inc Annual Cash Flow from Operations for 2017 was $-25m a 48.35% decrease of -12m from 2016
  • Arcus Biosciences Inc Annual Cash Flow from Operations for 2016 was $-13m
Other Cash Flow Metrics:
  • Arcus Biosciences Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-5m
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS Cash Flow from Operations Data

12/2018$-7m
09/2018$-12m
06/2018$-11m
03/2018$-13m
12/2017$16m
09/2017$-24m
06/2017$-7m
03/2017$-10m

Annual RCUS Cash Flow from Operations Data

2018$-43m
2017$-25m
2016$-13m